Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication

Journal of Virology

Volumn 76, Issue 8, 2002, Pages 4138-4144

  Pierson, Theodore C ^a   Kieffer, Tara L ^a   Ruff, Christian T ^a   Buck, Christopher ^a   Gange, Stephen J ^a   Siliciano, Robert F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR;

ARTICLE; CELL DEATH; CELL DIVISION; EPISOME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; T LYMPHOCYTE; VIRUS GENOME; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; DNA, CIRCULAR; DNA, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; PLASMIDS; VIRUS REPLICATION;

EID: 0036200163     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.8.4138-4144.2002     Document Type: Article

References (36)

1. Human immunodeficiency virus cDNA metabolism studied by fluorescence-monitored PCR: Notable stability of two-long terminal repeat circles
2. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
3. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
4. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
5. Changes in thymic function with age and during the treatment of HIV infection
6. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro
7. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication
8. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
9. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
10. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy
11. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
12. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
13. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells
14. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy
15. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA
16. Circular DNA of human immunodeficiency virus: Analysis of circle junction nucleotide sequences
17. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases
18. Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions
19. In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: A comparative study with other relevant HIV protease inhibitors
20. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
21. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding
22. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavir in vitro
23. Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: Association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS
24. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo
25. Decay characteristics of HIV-1-infected compartments during combination therapy
26. + T lymphocytes in infected children
27. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
28. Mapping unintegrated avian sarcoma virus DNA: Termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA
29. Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus
30. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
31. Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1
32. Sequence of the circle junction of human immunodeficiency virus type 1: Implications for reverse transcription and integration
33. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
34. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
35. Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression
36. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis